Formulation and evaluation of oral fast dissolving tablets of sildenafil citrarte

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue SUPPL. 2, 2011, Pages 112-121

  Sivakranth, M ^a   Althaf, Abdul S ^a   Rajasekhar, S ^b  

^a SRI VENKATESWARA UNIVERSITY   (India)

^b Srikrupa Institute of Pharmaceutical Sciences   (India)

Author keywords

Crospovidone; In vitro disintegration; In vitro dissolution; Sildenafil citrate; Viagra

Indexed keywords

CROSCARMELLOSE SODIUM; CROSPOVIDONE; SILDENAFIL NITRATE;

ARTICLE; BULK DENSITY; DRUG GRANULATION; DRUG MARKETING; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; ERECTILE DYSFUNCTION; INFRARED SPECTROSCOPY; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET PROPERTY;

EID: 84855469139     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Brahmankar D. M., Jaiswal S.B., Biopharmaceutics & Pharmaceutics, 1st Edition, 1995.
2. Howard C. Ansel, Nicholas G. Popvich, Loyd V. Allen, Pharmaceutical Dosage Forms and Drug Delivery System, First Edition, 1995.
3. Lindgren S, Janzon L. Dysphagia: prevalence of swallowing complaints and clinical.finding. Med Clin North Am 1993; 77:3-5.
4. Sastry SV, Nyshadham JR, Fx JA. Recent technological advances in oral drug delivery.A review. Pharm Sci Technol Today 2000; 3(4):138-145.
5. S. S. Biradar, S. T. Bhagavati and I. J. Kuppasad, Fast Dissolving Drug Delivery Systems: A Brief Overview, Internet J. Pharmacology, 2006, 4(2).
6. Kuccherkar B.S., Badhan A.C., Mahajan H.S., Mouth dissolving tablets: A novel drug delivery system, Pharma Times, 2003, 35, 3-10.
7. Lachmann L., Liebermann H. A. and Kiang J.L., The theory and practice of Industrial Pharmacy, Third Edition, Varghese Publishing House, Bombay, 1998.
8. Tablets: Formulation of tablets/Disintegration, www.pharmpedia.com, 2006.
9. Shah U. and Augsburger L., Evaluation of the functional equivalence of crospovidone NF from different sources: standard performance test, Pharm. Develop. Tech., 2001, 6, 419-430.
10. Boolell et al., 1996a M. Boolell, M.J. Allen, S.A. Ballard, S. Gepi- Attee, G.J. Muirhead, A.M. Naylor, I.H. Osterloh and C. Gingell, An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction, Int. J. Impot. Res. 1996, 47-52.
11. Cooper J, Gun C, Powder Flow and Compaction, Tutorial Pharmacy, New Delhi, CBS Publishers and Distributors,1986, 211-233.
12. Indian Pharmacopoeia, Fourth Edition, controller of Publication., Govt. of India., New Delhi,1996, A-86.
13. Vogel, A. I. A text book of quantitave in-organic anlysis. 3rd ed. p. 35.ELBS and Longman. 1969.
14. The British pharmacopoeia, Department of health by stationary office on behalf of the medicine and health care product regulatory agency, Crown Copy Right, 5th edition. 2005; 1303-1304, 2588-2589, A133.
15. The United State Pharmacopoeia 24/NF19, Asian edition, the official compendia of standard United States Pharmacopoeial Convection Inc. Rockville.1995; pp:1015-1016, 1791.
16. Qalaji-Rawas MM, Simons ER and Simons KJ. "Fast disintegrating Sublingual Tablets: Effect of Epinephrine Load on Tablet Characteristics",AAPS PharmSciTech., 2006; 7(2)
17. Kulkarni G T, Gowathamarajan K, Suresh B, Stability testing of Pharmaceutical product: an overview, Ind. J. Pharm. Sci., 2004, 38(4), 194-202.
18. ICH Q1A (R2), Stability Testing Guidelines, Stability testing of a new drug product and new drug substance.